Hydrochlorothiazide Tablet
Product Images NDC 51655-674

2 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydrochlorothiazide (NDC 51655-674). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (Chemstructure)

Chem Structure (Chemstructure)
Chemical structure of Hydrochlorothiazide, showing the molecular formula C7H8ClN3O4S2 and molecular weight 297.74. The structure includes a benzene ring with chlorine, sulfonamide, and other functional groups characteristic of hydrochlorothiazide.*
FDA Label Image

Label (51655 674 52 Rev A 02 23 Nhc)

Label (51655 674 52   Rev A 02 23 Nhc)
HYDROCHLOROTHIAZIDE Tablets USP 12.5 mg oral tablets packaging label shows a quantity of 30 tablets. It includes storage instructions to keep at 20°-25°C (68°-77°F) and mentions it is Rx only. The labeler is Northwind Health Company, LLC, with NDC number 51655-674-52.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.